A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Opinion Development |
---|---|
Submitter | Denmark |
Submitter email | mst@mst.dk |
Regulatory programme |
|
Further substance information | All identified IUPAC names: (1,3-benzodioxol-5-yl)-2-methyl propanal (2R)-3-(1,3-benzodioxol-5-yl)-2-methylpropanal 2-Methyl-3-(3,4 methylendioxylphenyl)-propanal 2-methyl-3-(3,4-methylene dioxyphenyl)-propanal 2-Methyl-3-(3,4-methylenedioxyphenyl)propionaldehyde 3-(1,3-Benzodioxol-5-yl)-2-methylpropanal 3-(2H-1,3-benzodioxol-5-yl)-2-methylpropanal 3-(3,4-methylenedioxyphenyl)-2-2-methylpropanal 5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione alpha-Methyl-1,3-benzodioxole-5-propionaldehyde alpha-Methyl-3,4-methylene-dioxyhydrocinnamicaldehyde |
Classification
Proposed harmonised classification by the dossier submitter |
|
---|---|
Hazard classes open for commenting | Skin sensitisation |
Intention timeline
Date of intention | 2020-08-11 |
---|---|
Expected date of submission | 2020-12-31 |
Submitted for accordance check | 2020-10-05 |
Final submission date | 2021-06-01 |
Start of consultation | 2021-08-09 |
Deadline for commenting | 2021-10-08 |
Legal deadline for opinion adoption | 2022-12-01 |
Documents
CLH report |
|
---|---|
Annexes to the CLH Report |
|
Comments received |
|
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
April 26, 2022
- Date of opinion: 2022-03-18
- Status: Opinion Development → Opinion Adopted
June 6, 2022
- Comments received: https://echa.europa.eu/documents/10162/b0b3a845-9a78-4743-532e-4bcb1bbf2ae8
June 24, 2022
- Background document: https://echa.europa.eu/documents/10162/072b617c-70b2-68c8-c841-8f194c2f0d3b
- Comments received: https://echa.europa.eu/documents/10162/ab4928c1-2783-aecc-11d5-acb8151d0c6e
- RAC opinion: https://echa.europa.eu/documents/10162/e8c418c1-4203-e9f0-5bdb-3796ebb4d2a1
This version
Oct. 27, 2021
- Comments received: https://echa.europa.eu/documents/10162/b0b3a845-9a78-4743-532e-4bcb1bbf2ae8
Oct. 19, 2021
- Status: Consultation → Opinion Development
Oct. 8, 2021
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/9fa4e640-fcb9-e0f6-32a0-f6a351f6cfe5
- CLH report: https://echa.europa.eu/documents/10162/a26f3630-4c62-394f-2171-447c862c14bd
- Deadline for commenting: 2021-10-08
- Final submission date: 2021-06-01
- Hazard classes open for commenting: Skin sensitisation
- Legal deadline for opinion adoption: 2022-12-01
- Status: Submitted → Consultation
- Start of consultation: 2021-08-09
April 9, 2021
- Name: 3-(1,3-benzodioxol-5-yl)-2-methylpropanal → α-methyl-1,3-benzodioxole-5-propionaldehyde
March 31, 2021
- Name: α-methyl-1,3-benzodioxole-5-propionaldehyde → 3-(1,3-benzodioxol-5-yl)-2-methylpropanal
Add the related substance to your watchlist to monitor this regulatory record.